Grant: Operating Grant: Alzheimer Society Research Program - NI Grants
McGill University
$200,000.00
Deciphering the molecular events weakening neuronal connections in Alzheimer's disease
FY 2023-24
Summary
Alzheimer’s is characterized by the progressive loss of cognitive functions. Cognition depends on the millions of
interactions among neurons inhabiting the brain. Hammering the loss and dysfunction of neuronal interactions and
the accumulation of two pathological aggregates are the first physiological indicators of Alzheimer’s disease. They
appear before the symptoms, providing a window to apply therapies that sustain neuronal interactions.
We recently discovered molecular events critical for neurons to uphold healthy interaction. Our goal is to determine
whether Alzheimer’s pathological aggregates disrupt them. Because aging is the highest risk of suffering from
Alzheimer’s, we will also investigate the impact of aging on dampening the molecular events sustaining
connections and their relation to the disease.
The lack of technologies precise enough to study the composition of individual interneural interactions has
impaired the development of efficient therapies to preserve them. My lab has leveraged imaging techniques to see
essential aspects of the molecules in charge of keeping neuronal interactions healthy. Applying these powerful
techniques in Alzheimer’s disease mouse models and tissue samples of deceased patients will elucidate the impact
of the disease on the presence of these molecules at neuronal interactions.
A common characteristic of Alzheimer’s and other dementias is their progressive nature and lack of treatment. Even
when the disease is diagnosed at the very early stages, we cannot slow down or stop neurons from losing their
connections. The more connections lost the more advanced the cognitive impairment. Results from our project
provide the opportunity to understand the etiology of neuronal connection loss and strengthen them to slow down
disease advance and preserve cognition.
The relevance is to provide a molecular explanation of the disease symptoms and the consequent therapeutical
opportunity.
Department
Program
Operating Grant: Alzheimer Society Research Program - NI Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
505441
Name
Vera Ugalde Maria
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
Deciphering the molecular events weakening neuronal connections in Alzheimer's disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$200,000
Cihrequipment2
$0
Programname2
Operating Grant: Alzheimer Society Research Program - NI Grants
Keyworddelim
Alzheimer’S Disease; Biomedical & Discovery; Neuronal Interactions; Neurons
Abstract
Alzheimer’s is characterized by the progressive loss of cognitive functions. Cognition depends on the millions of
interactions among neurons inhabiting the brain. Hammering the loss and dysfunction of neuronal interactions and
the accumulation of two pathological aggregates are the first physiological indicators of Alzheimer’s disease. They
appear before the symptoms, providing a window to apply therapies that sustain neuronal interactions.
We recently discovered molecular events critical for neurons to uphold healthy interaction. Our goal is to determine
whether Alzheimer’s pathological aggregates disrupt them. Because aging is the highest risk of suffering from
Alzheimer’s, we will also investigate the impact of aging on dampening the molecular events sustaining
connections and their relation to the disease.
The lack of technologies precise enough to study the composition of individual interneural interactions has
impaired the development of efficient therapies to preserve them. My lab has leveraged imaging techniques to see
essential aspects of the molecules in charge of keeping neuronal interactions healthy. Applying these powerful
techniques in Alzheimer’s disease mouse models and tissue samples of deceased patients will elucidate the impact
of the disease on the presence of these molecules at neuronal interactions.
A common characteristic of Alzheimer’s and other dementias is their progressive nature and lack of treatment. Even
when the disease is diagnosed at the very early stages, we cannot slow down or stop neurons from losing their
connections. The more connections lost the more advanced the cognitive impairment. Results from our project
provide the opportunity to understand the etiology of neuronal connection loss and strengthen them to slow down
disease advance and preserve cognition.
The relevance is to provide a molecular explanation of the disease symptoms and the consequent therapeutical
opportunity.
Competitiondate
202311
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Vera Ugalde, Maria
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $200,000~ $0~